Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Depreciation and Depletion (2016)

Historic Depreciation and Depletion for Cross Country Healthcare (CCRN) over the last 7 years, with Q4 2016 value amounting to $1.1 million.

  • Cross Country Healthcare's Depreciation and Depletion rose 1624.74% to $1.1 million in Q4 2016 from the same period last year, while for Dec 2016 it was $4.2 million, marking a year-over-year increase of 809.13%. This contributed to the annual value of $4.2 million for FY2016, which is 809.13% up from last year.
  • Latest data reveals that Cross Country Healthcare reported Depreciation and Depletion of $1.1 million as of Q4 2016, which was up 1624.74% from $995000.0 recorded in Q3 2016.
  • Cross Country Healthcare's Depreciation and Depletion's 5-year high stood at $1.6 million during Q1 2012, with a 5-year trough of $817000.0 in Q2 2014.
  • Over the past 5 years, Cross Country Healthcare's median Depreciation and Depletion value was $1.0 million (recorded in 2014), while the average stood at $1.0 million.
  • As far as peak fluctuations go, Cross Country Healthcare's Depreciation and Depletion plummeted by 3584.43% in 2013, and later soared by 2105.26% in 2015.
  • Over the past 5 years, Cross Country Healthcare's Depreciation and Depletion (Quarter) stood at $1.1 million in 2012, then fell by 15.63% to $934000.0 in 2013, then rose by 14.56% to $1.1 million in 2014, then fell by 10.84% to $954000.0 in 2015, then grew by 16.25% to $1.1 million in 2016.
  • Its Depreciation and Depletion stands at $1.1 million for Q4 2016, versus $995000.0 for Q3 2016 and $1.1 million for Q2 2016.